Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-08T03:27:51.521Z Has data issue: false hasContentIssue false

Estimation of the intake of anthocyanidins and their food sources in the European Prospective Investigation into Cancer and Nutrition (EPIC) study

Published online by Cambridge University Press:  12 April 2011

Raul Zamora-Ros*
Affiliation:
Unit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, IDIBELL, Barcelona, Spain
Viktoria Knaze
Affiliation:
Unit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, IDIBELL, Barcelona, Spain
Leila Luján-Barroso
Affiliation:
Unit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, IDIBELL, Barcelona, Spain
Nadia Slimani
Affiliation:
Dietary Exposure Assessment Group, International Agency for Research on Cancer (IARC), Lyon, France
Isabelle Romieu
Affiliation:
Dietary Exposure Assessment Group, International Agency for Research on Cancer (IARC), Lyon, France
Marina Touillaud
Affiliation:
Dietary Exposure Assessment Group, International Agency for Research on Cancer (IARC), Lyon, France
Rudolf Kaaks
Affiliation:
Department of Cancer Epidemiology, German Cancer Research Centre, Heidelberg, Germany
Birgit Teucher
Affiliation:
Department of Cancer Epidemiology, German Cancer Research Centre, Heidelberg, Germany
Amalia Mattiello
Affiliation:
Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy
Sara Grioni
Affiliation:
Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Francesca Crowe
Affiliation:
Cancer Epidemiology Unit, University of Oxford, Oxford, UK
Heiner Boeing
Affiliation:
Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany
Jana Förster
Affiliation:
Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany
J. Ramón Quirós
Affiliation:
Public Health and Health Planning Directorate, Asturias, Spain
Esther Molina
Affiliation:
Andalusian School of Public Health, Granada, Spain CIBER Epidemiología y Salud Pública (CIBERESP), Spain
José María Huerta
Affiliation:
CIBER Epidemiología y Salud Pública (CIBERESP), Spain Department of Epidemiology, Murcia Regional Health Authority, Murcia, Spain
Dagrun Engeset
Affiliation:
Department of Community Medicine, University of Tromsø, Tromsø, Norway
Guri Skeie
Affiliation:
Department of Community Medicine, University of Tromsø, Tromsø, Norway
Antonia Trichopoulou
Affiliation:
WHO Collaborating Centre for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece Hellenic Health Foundation, Athens, Greece
Vardis Dilis
Affiliation:
WHO Collaborating Centre for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece Hellenic Health Foundation, Athens, Greece
Konstantinos Tsiotas
Affiliation:
WHO Collaborating Centre for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece
Petra H. M. Peeters
Affiliation:
Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, Imperial College, London, UK
Kay-Thee Khaw
Affiliation:
University of Cambridge School of Clinical Medicine, Cambridge, UK
Nicholas Wareham
Affiliation:
MRC Epidemiology Unit, Cambridge, UK
Bas Bueno-de-Mesquita
Affiliation:
National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands Department of Gastroenterology and Hepatology, University Medical Centre Utrecht (UMCU), Utrecht, The Netherlands
Marga C. Ocké
Affiliation:
National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Anja Olsen
Affiliation:
Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark
Anne Tjønneland
Affiliation:
Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark
Rosario Tumino
Affiliation:
Cancer Registry and Histopathology Unit, ‘Civile M.P. Arezzo’ Hospital, Ragusa, Italy
Gerd Johansson
Affiliation:
Department of Clinical Medicine and Public Health/Nutritional Research, Umeå University, Umeå, Sweden
Ingegerd Johansson
Affiliation:
Department of Odontology/Cariology, Umeå University, Umeå, Sweden
Eva Ardanaz
Affiliation:
CIBER Epidemiología y Salud Pública (CIBERESP), Spain Navarre Public Health Institute, Pamplona, Spain
Carlotta Sacerdote
Affiliation:
Centre for Cancer Prevention (CPO-Piemonte), and Human Genetic Foundation (HuGeF), Torino, Italy
Emily Sonestedt
Affiliation:
Diabetes and Cardiovascular Disease, Genetic Epidemiology, Department of Clinical Sciences, Lund University, Malmö, Sweden
Ulrika Ericson
Affiliation:
Diabetes and Cardiovascular Disease, Genetic Epidemiology, Department of Clinical Sciences, Lund University, Malmö, Sweden
Françoise Clavel-Chapelon
Affiliation:
INSERM, Centre for Research in Epidemiology and Population Health, U1018, Institut Gustave Roussy, Villejuif, France Paris South University, UMRS 1018, Villejuif, France
Marie-Christine Boutron-Ruault
Affiliation:
INSERM, Centre for Research in Epidemiology and Population Health, U1018, Institut Gustave Roussy, Villejuif, France Paris South University, UMRS 1018, Villejuif, France
Guy Fagherazzi
Affiliation:
INSERM, Centre for Research in Epidemiology and Population Health, U1018, Institut Gustave Roussy, Villejuif, France Paris South University, UMRS 1018, Villejuif, France
Simonetta Salvini
Affiliation:
Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute – ISPO, Florence, Italy
Pilar Amiano
Affiliation:
CIBER Epidemiología y Salud Pública (CIBERESP), Spain Public Health Department of Guipuzkoa, Instituto Investigación Sanitaria BioDonostia, Basque Government, San Sebastian, Spain
Elio Riboli
Affiliation:
Department of Epidemiology, Public Health and Primary Care, Imperial College, London, UK
Carlos A. González
Affiliation:
Unit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, IDIBELL, Barcelona, Spain
*
*Corresponding author: Dr Raul Zamora-Ros, fax +34 932607787, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Anthocyanidins are bioactive flavonoids with potential health-promoting effects. These may vary among single anthocyanidins considering differences in their bioavailability and some of the mechanisms involved. The aim of the present study was to estimate the dietary intake of anthocyanidins, their food sources and the lifestyle factors (sex, age, BMI, smoking status, educational level and physisical activity) involved among twenty-seven centres in ten European countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Anthocyanidin intake and their food sources for 36 037 subjects, aged between 35 and 74 years, in twenty-seven redefined centres were obtained using standardised 24 h dietary recall software (EPIC-SOFT). An ad hoc food composition database on anthocyanidins (cyanidin, delphinidin, malvidin, pelargonidin, peonidin, petunidin) was compiled using data from the US Department of Agriculture and Phenol-Explorer databases and was expanded by adding recipes, estimated values and cooking factors. For men, the total anthocyanidin mean intake ranged from 19·83 (se 1·53) mg/d (Bilthoven, The Netherlands) to 64·88 (se 1·86) mg/d (Turin, Italy), whereas for women the range was 18·73 (se 2·80) mg/d (Granada, Spain) to 44·08 (se 2·45) mg/d (Turin, Italy). A clear south to north gradient intake was observed. Cyanidins and malvidins were the main anthocynidin contributors depending on the region and sex. Anthocyanidin intake was higher in non-obese older females, non-smokers, and increased with educational level and physical activity. The major food sources were fruits, wine, non-alcoholic beverages and some vegetables. The present study shows differences in both total and individual anthocyanidin intakes and various lifestyle factors throughout Europe, with some geographical variability in their food sources.

Type
Full Papers
Copyright
Copyright © The Authors 2011

Anthocyanidins are water-soluble plant pigments that form one subgroup of flavonoids. They mainly provide the red, blue and purple colours to fruits, vegetables and flowers. Chemically, they are derivative salts of the flavilium cation. Anthocyanins are glycosides of anthocyanidins, and their sugar moiety (glucose, galactose, rhamnose, xylose and fructose) is mostly bounded to the C3 position of the C-ring(Reference Clifford1). Diglycosides have also been reported, but in smaller amounts(Reference Clifford1).

In nature, more than 500 anthocyanins derived from thirty-one anthocyanidins have been identified(Reference Anderson, Jordheim, Anderson and Markham2). However, only six anthocyanidins (cyanidin, delphinidin, malvidin, pelargonidin, peonidin and petunidin) occur ubiquitously and have dietary importance. They are found in fruits, such as berries, red grapes, cherries, and plums; in vegetables, such as red cabbage, red onions, radish and aubergines; and also in fruit and vegetable products, such as juices and wines(3, Reference Perez-Jimenez, Neveu and Vos4). The anthocyanidin content is enhanced during the ripening process. Moreover, these flavonoids are found mainly in the skin of fruit, except in berries where they are in the skin and flesh(Reference Manach, Scalbert and Morand5).

Some epidemiological studies suggest that the consumption of anthocyanidins decreases the risk of total mortality(Reference Fink, Steck and Wolff6) and CVD(Reference Tavani, Spertini and Bosetti7, Reference Mink, Scrafford and Barraj8) due, in part, to their antioxidant and anti-inflammatory activities(Reference Prior and Wu9). There is also much in vitro and in vivo evidence in animal models about their anti-carcinogenic properties(Reference Prior and Wu9, Reference Wang and Stoner10), but findings in human subjects are still controversial. Anthocyanidin intake has been associated with a decreased risk of some cancers, especially digestive system cancers(Reference Bobe, Peterson and Gridley11Reference Rossi, Negri and Talamini15), but, in other epidemiological studies, these significant associations were not observed(Reference Fink, Steck and Wolff6, Reference Bobe, Sansbury and Albert16Reference Rossi, Negri and Lagiou25).

All anthocyanidins are poorly absorbed (usually less than 0·1 %, but up to 5 % has been reported), highly metabolised (more than 65 % is detected in glucuronidated and methylated forms in serum) and rapidly excreted in urine (about 4 h elimination half-life)(Reference Prior and Wu9). Differences in the chemical structure of some anthocyanidins also determine their bioavailability; for example, pelargonidin-3-glucoside has an 8-fold higher apparent absorption rate than cyanidin-3-glucoside(Reference Felgines, Talavera and Gonthier26). In the same way, several activities of anthocyanidins depend on their chemical structure(Reference Prior and Wu9). For example, delphynidins and cyanidins are able to inhibit lipopolysaccharide-induced cyclo-oxygenase-2 expression, but pelargonidins, peonidins and malvidins are not(Reference Hou, Yanagita and Uto27). For these reasons, further studies are needed, comparing individual anthocyanidin bioavailability and metabolic actions.

To date, there are few population-based descriptive studies of anthocyanidin intake(Reference Johannot and Somerset28, Reference Chun, Chung and Song29), especially in European countries(Reference Zamora-Ros, Andres-Lacueva and Lamuela-Raventos30, Reference Ovaskainen, Torronen and Koponen31). The previous studies mainly reported associations between anthocyanidins and markers of disease risk. In general, these studies evaluated anthocyanidins as a group rather than exploring individual anthocyanidins; furthermore, main food sources were not reported. The aims of the present study were to estimate the consumption of the six most important anthocyanidins and their main food sources across the ten European countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) study and across population subgroups.

Materials and methods

Study population

EPIC is an ongoing prospective cohort study designed to investigate the associations between diet, lifestyle and cancer throughout ten western European countries: Denmark, France, Germany, Greece, Italy, Norway, Spain, Sweden, The Netherlands and the UK(Reference Riboli and Kaaks32, Reference Riboli, Hunt and Slimani33). The cohort includes approximately 366 000 women and 153 000 men, most aged 35–70 years, who were enrolled between 1992 and 2000. Participants were mostly recruited from the general population residing within defined geographical areas, with some exception: women members of a health insurance scheme for state school employees (France); women attending breast cancer screening (Utrecht in The Netherlands and Florence in Italy); mainly blood donors (centres in Italy and Spain); and a cohort consisting predominantly of vegetarians (the ‘health-conscious’ cohort in Oxford, UK)(Reference Riboli, Hunt and Slimani33). The initial twenty-three EPIC administrative centres were redefined into twenty-seven geographical regions relevant to the analysis of dietary consumption patterns(Reference Slimani, Kaaks and Ferrari34). Of the twenty-seven EPIC centres redefined for dietary analysis, nineteen had both male and female participants, and eight recruited only women (France, Norway, Utrecht in The Netherlands and Naples in Italy).

For calibration purposes, a standardised 24 h dietary recall (24-HDR) interview was administered to a stratified random sample (36 994) by age, sex and centre, and weighted for expected cancer cases in each stratum. A total of 36 037 subjects with 24-HDR data were included in this analysis, after exclusion of 941 subjects aged less than 35 years of age or over 74 years because of low participation in these age categories, and sixteen subjects were excluded due to missing FFQ data. Approval for the EPIC study was obtained from all ethical review boards of participating institutions. All participants provided written informed consent.

Dietary and lifestyle information

The 24-HDR was administered in a face-to-face interview, except in Norway, where it was obtained by telephone interview(Reference Brustad, Skeie and Braaten35). A computerised interview program (EPIC-SOFT) was developed specifically for the calibration study(Reference Slimani, Ferrari and Ocke36, Reference Slimani, Deharveng and Unwin37). A complete description of the rationale, methodology and population characteristics of the 24-HDR calibration study has been described elsewhere(Reference Slimani, Kaaks and Ferrari34). The original diet and health survey from which information used in the present study was obtained had ethical approval from all ethical review boards of participating institutions.

Data on other lifestyle factors, including educational level, anthropometry, physical activity and smoking history, were collected at baseline through standardised questionnaires and clinical examinations, and have been described elsewhere(Reference Riboli, Hunt and Slimani33, Reference Slimani, Kaaks and Ferrari34, Reference Haftenberger, Schuit and Tormo38). Data on age, as well as on body weight and height, were self-reported by the participants during the 24-HDR interview. The mean time interval between completion of the baseline questionnaire measures and the 24-HDR interview varied by country, and ranged from 1 d to 3 years later(Reference Slimani, Kaaks and Ferrari34).

Food composition database

In order to estimate the anthocyanidin (cyanidin, delphynidin, malvidin, pelargonidin, peonidin and petunidin) intake from the 24-HDR, a food composition database (FCDB) was developed, which contained 1877 food items (annex table 1; see supplementary material available online at http://www.journals.cambridge.org/bjn). Anthocyanidins are expressed as anthocyanidin aglycones per 100 mg fresh weight and are calculated as the sum of the available forms (glycosides and aglycones) in the literature.

Our database is based on the US Department of Agriculture (USDA) database(3) and expanded with values from Phenol-Explorer(Reference Neveu, Perez-Jimenez and Vos39). Approximately, 5 and 1 % of our database come from USDA and Phenol-Explorer databases, respectively. To date, these two databases are the most complete and updated databases on flavonoids and polyphenols and they evaluate and compile the most worldwide food composition data published. There are no large differences on the anthocyanidin data between the two databases.

One cannot assume that foods that are not in either of the databases do not contain anthocyanidins. Therefore, for our FCDB we calculated estimated values (89 %) including logical zeros (26 %), estimations based on similar food items (15 %), application of retention factors (29 %) and recipes (19 %). First, logical zeros were applied when no anthocyanidins are expected in a food (for example, animal foods or plant foods without colour, because anthocyanidins are plant pigments). Second, estimations based on similar food items were applied when it was possible to extrapolate the composition from one food to another similar one (for example, different varieties of blueberries). Third, when there was no analytical data for cooked food, retention factors were applied. These were 70, 35 and 25 % after frying, cooking in a microwave oven, and boiling, respectively(Reference Crozier, Lean and McDonald40). Crozier et al. (Reference Crozier, Lean and McDonald40) calculated these retention factors for flavonols, but these are quite similar to the average of anthocyanidin retention factors available in the literature by each cooking method(Reference Hiemori, Koh and Mitchell41Reference Oliveira, Amaro and Pinho45), although further investigation is needed in this regard. Recipes were applied when it was feasible to deconstruct the food item into a list of available ingredients in our FCDB. Finally, only 4 % of our FCDB had missing values, which are calculated as a zero by default.

Statistical analyses

Dietary intake data are presented as means (least square means) and standard errors stratified by sex and study centre and ordered according to a geographical south to north gradient. The mean intake data were adjusted for age. The contribution of each food group to the total intake of anthocyanidins was calculated as a percentage. Differences in anthocyanidin intake stratified by sex were also compared according to the categories of age, educational level, smoking status, level of physical activity, BMI and European region (south: all centres in Greece, Spain, Italy and the south of France centre; central: all of France other than the south centre, all centres in Germany, The Netherlands and the UK; north: all centres in Denmark, Sweden and Norway). These models were adjusted for age, region, BMI and energy intake. All models were weighted by season and day of the week of the 24-HDR using generalised linear models to control for different distributions of 24-HDR interviews across seasons and days of the week. All analyses were conducted using SPSS Statistics software (version 17.0; SPSS Inc., Chicago, IL, USA).

Results

The mean intakes and for single and total anthocyanidins stratified by centre and sex, adjusted for age, and weighted by season and day of the week are shown in Table 1. For men, the total anthocyanidin intake ranged from 19·83 mg/d (Bilthoven, The Netherlands) to 64·88 mg/d (Turin, Italy), whereas for women the range was from 18·73 mg/d (Granada, Spain) to 44·08 mg/d (Turin, Italy). The main anthocyanidin contributors (Table 2) were malvidin (42·7 % in men and 29·4 % in women) and cyanidin (38·0 % in men and 49·9 % in women) in the southern region, cyanidin (45·6 % in men and 46·8 % in women) in the central region, and cyanidin (34·0 % in men and 36·8 % in women) and malvidin (33·0 % in men and 30·5 % in women) in the northern European region.

Table 1 Adjusted* daily intakes (mg/d) of total and single anthocyanidins by sex and centre ordered from south to north

(Mean values with their standard errors)

* Adjusted for age and weighted by season and day of recall.

Table 2 Percentage contribution* of intakes of individual anthocyanidins in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort by European region and sex

* Adjusted for age and weighted by season and day of recall.

Table 3 shows the assessment of the effect of certain lifestyle factors on anthocyanidin intake adjusted for sex, age, BMI and energy intake (where appropriate) and weighted by season and day of the week. In south European countries, men consumed more anthocyanidins than women of these countries, whereas in north European countries, they consumed similar amounts, and in central European countries women ingested greater quantities than men. The difference in intake between the sexes in south European countries was due to malvidin intake which in men was two-fold that of women. A geographical gradient of increasing total anthocyanidin, cyanidin, malvidin and peonidin intakes from north to south Europe was observed. However, there was an inverse regional gradient for delphynidin intake. Older individuals consumed more anthocyanidins, with a maximum intake in those aged 55–64 years. There were positive trends when assessing total anthocyanidin intakes and educational level, smoking status (comparing current v. never or former smokers), BMI (obese v. normal or overweight) and physical activity.

Table 3 Adjusted* daily intakes (mg/d) of total and single anthocyanidins by sex and selected characteristics

(Mean values with their standard errors)

* Adjusted for sex, age, region, energy intake, and BMI (where appropriate) and weighted by season and day of recall.

The main food sources of anthocyanidin intake by European region were also studied (Table 4). The group of fruits, nuts and seeds (mainly non-citrus fruit such as grapes, apples and pears) contributed most of the total anthocyanidin intake. In south, central and north European countries this food group contributed 61·2, 52·9 and 38·1 %, respectively. Other major food sources were wine (contributions ranged from 14·4 to 24·5 %), followed by non-alcoholic beverages, such as carbonated, soft and isotonic drinks in northern European countries (15·8 %) and fruit and vegetable juices in central European countries (13·4 %), and some types of vegetables (ranging from 4·8 to 9·7 %). The major food sources of cyanidins were fruits and non-alcoholic beverages derived from either fruits and vegetables or carbonated, soft and isotonic drinks. For delphynidins, the main contributors in southern countries were wine, bananas, grapes and fruiting vegetables, mainly aubergine. However, in central and northern countries the richest sources were banana, non-alcoholic beverages, berries and wine. Malvidins were almost exclusively derived from grape and wine products. The main contributors to pelargonidins were berries, followed by root vegetables and dairy products with berries as ingredients. We identified fruits, wine and non-alcoholic beverages (only in the north and central European countries) as the most abundant sources of peonidins and petunidins.

Table 4 Percentage contribution of food groups and some main foods to the intake of total and single anthocyanidins by European region*

* Values are percentages derived from models adjusted for age and sex and weighted by season and day of recall. There were differences between European regions for all food sources (P < 0·001), except for food sources where anthocyanidin contributions are less than 0·2 % for all regions (NS differences).

Leafy vegetables include red leaf lettuce, red chicory, radicchio and trevise (red Treviso lettuce); fruiting vegetables include aubergines; root vegetables include beetroot, red radish and black radish; cabbages include red cabbage and Chinese cabbage; stone fruits include plums, peaches, nectarines, apricots, mangoes and paraguayos; other and mixed fruits include cherries, red fruit not specified, sour cherries, persimmon, sharon fruit and pomegranate; cereal, cakes and confectionery include fruit cakes, biscuits with jam and plum cake; fruit and vegetable juices include blackcurrant juice, cranberry juice, redcurrant juice, cherry juice, peach juice, apricot juice, plum juice and beetroot juice; carbonated, soft and isotonic drinks include blackcurrant syrups, syrups of fruits and berries, cherry coke, pommac and jaffa; soups and bouillons include bilberry soup, berry soup and elderberry soup.

Discussion

To our knowledge, this is the first study to estimate the intake of anthocyanidins and their main food sources in a large adult European cohort, evaluating differences across ten European countries and the most important determinant factors. The use of a unique FCDB on anthocyanidins and the same methodology in the dietary assessment for the whole cohort provided more comparable results across the countries. The FCDB was compiled at the end of 2009 using the most updated and available worldwide databases(3, Reference Neveu, Perez-Jimenez and Vos39) on flavonoids and polyphenols. Furthermore, our database was expanded with recipes, estimations by food or food group and the application of cooking factors(Reference Crozier, Lean and McDonald40). However, the use of different FCDB and different food surveys limits the comparisons between studies.

In men, there were great differences in anthocyanidin intakes across EPIC centres, ranging from 19·83 mg/d in Bilthoven to 64·88 mg/d in Turin. Indeed, the south European region had the highest consumption of total anthocyanidins, and the two main individual anthocyanidins (cyanidins and malvidins). Moreover, regional trends of increasing anthocyanidin, cyanidin, malvidin and peonidin intakes from northern to southern countries were also observed. Meanwhile, women from central and southern regions were the highest anthocyanidin consumers. Individuals aged 55–64 years, who had a university degree, non-smokers (former or never smokers), those doing moderate or active physical activity and those that were overweight (BMI 25 to <  30 kg/m2) had the highest anthocyanidin consumption. Part of these differences was due to the differences in the consumption pattern of the major food sources in the European countries. For example, in southern countries, a high intake of wine(Reference Sieri, Krogh and Saieva46), non-citrus fruits (especially grapes, stone fruits, apples and pears, and olives) and leafy vegetables(Reference Agudo, Slimani and Ocke47) was observed. However, in central and northern countries the main contributors were non-citrus fruits (mainly berries, apples and pears, and grapes), wine and, finally, non-alcoholic beverages (juices and soft drinks of anthocyanidin-rich fruits). The large differences in anthocyanidin intakes between men (45·47 mg/d) and women (31·73 mg/d) in the southern region (Italy, Spain, Greece) were due to the high consumption of red wine, which is very rich in malvidins, as observed in a previous Spanish cohort(Reference Zamora-Ros, Andres-Lacueva and Lamuela-Raventos30). The present results are comparable with previously published data of intakes in the southern European region; median intakes of 9·3 to 28·0 mg/d have been reported(Reference Tavani, Spertini and Bosetti7, Reference Rossi, Garavello and Talamini12Reference Rossi, Negri and Talamini15, Reference Bosetti, Spertini and Parpinel17, Reference Bosetti, Rossi and McLaughlin18, Reference Lagiou, Samoli and Lagiou21, Reference Peterson, Lagiou and Samoli24, Reference Rossi, Negri and Lagiou25, Reference Lagiou, Samoli and Lagiou48Reference Dilis and Trichopoulou50) although a Greek cohort was found to consume 52·6 mg/d(Reference Lagiou, Rossi and Lagiou22). Two previous studies in northern countries (Finland) also reported great differences in mean intakes; 5·9 mg/d in the Kuopio Ischaemic Heart Disease Risk Factor Study(Reference Mursu, Nurmi and Tuomainen23) and 47 mg/d in the FINDIET 2002 Study(Reference Ovaskainen, Torronen and Koponen31). In non-European countries, lower intakes have been observed than in European countries. For example, in the USA mean intakes were found to range from less than 1 to 10·1 mg/d(Reference Fink, Steck and Wolff6, Reference Bobe, Peterson and Gridley11, Reference Bobe, Sansbury and Albert16, Reference Cutler, Nettleton and Ross19, Reference Fink, Steck and Wolff20, Reference Chun, Chung and Song29), while in Australia 2·9 mg/d(Reference Johannot and Somerset28), and in Japan 11·3 mg/d(Reference Melby, Murashima and Watanabe51) were reported.

Cyanidins were the most prevalent anthocyanidins (34–50 %) except in men from the southern European region. Cyanidin intake ranged from 8·2 to 16·4 mg/d; these values are slightly higher than our previous results in Spain (6·2 mg/d)(Reference Zamora-Ros, Andres-Lacueva and Lamuela-Raventos30) and in Greece (4 mg/d)(Reference Dilis and Trichopoulou50), lower than Finland (25 mg/d)(Reference Ovaskainen, Torronen and Koponen31) and much higher than in Australia (0·42 mg/d)(Reference Johannot and Somerset28). In Finland the main contributors were berries and their derived products (88 %)(Reference Ovaskainen, Torronen and Koponen31), whereas in the present study berries and berry products (juices, soft drinks and soups) represented approximately 6, 31 and 37 % in southern, central and northern countries, respectively. In the present study, leafy vegetables, apples and pears, and stone fruits were also major food sources of cyanidins. Malvidin was the main anthocyanidin in men from the southern European region, which is in line with findings from our previous study in Spain(Reference Zamora-Ros, Andres-Lacueva and Lamuela-Raventos30) and in Australia(Reference Johannot and Somerset28). In the entire cohort and in the literature the main contributors were red wine and red grapes. Delphynidin was usually the third most abundant anthocyanidin (5·6 and 16·0 % in southern and northern countries, respectively). Moreover, a geographical trend was observed, with increasing intakes from south (0·8 mg/d women in Navarra, Spain) to north (5·8 mg/d women in Umeå, Sweden), as has previously been observed in Spain (2·5 mg/d)(Reference Zamora-Ros, Andres-Lacueva and Lamuela-Raventos30) and Finland (14 mg/d)(Reference Ovaskainen, Torronen and Koponen31). Pelargonidins (3·3–13·7 %), peonidins (4·3–5·4 %) and petunidins (2·3–6·3 %) were the least abundant anthocyanidins, similar to findings reported in previous papers(Reference Johannot and Somerset28, Reference Zamora-Ros, Andres-Lacueva and Lamuela-Raventos30, Reference Ovaskainen, Torronen and Koponen31).

Anthocyanidins have been shown to have protective effects in clinical and epidemiological studies, especially against some chronic diseases. In a US breast cancer case–control study, a reduction of all mortality at 6 years of follow-up after a high intake of anthocyanidins and other flavonoids(Reference Fink, Steck and Wolff6) was reported. Concerning CVD, an Italian case–control study observed a significant inverse trend between acute myocardial infarction and anthocyanidin intake, and an OR of 0·45 (95 % CI 0·26, 0·78) when comparing extreme quintiles(Reference Tavani, Spertini and Bosetti7). However, in two Greek case–control studies no associations were found between anthocyanidin consumption and peripheral arterial occlusive disease(Reference Lagiou, Samoli and Lagiou48) or CHD(Reference Lagiou, Samoli and Lagiou49). Indeed, in a recent meta-analysis, Hooper et al. concluded that there were insufficient data from clinical trials to confirm the beneficial effects on CVD(Reference Hooper, Kroon and Rimm52). Several epidemiological studies have suggested contradicting results regarding cancer. However, these differences can be explained, in part, by low anthocyanidin bioavailability (less than 5 %)(Reference Prior and Wu9) and the wide range of anthocyanidin intakes among studies. Overall, all cancers studied not related to the digestive system (breast, ovarian, prostate, lung, pancreatic, liver, renal cancers, and diffuse and follicular β-cell lymphomas) have not been significantly associated with anthocyanidin intake(Reference Fink, Steck and Wolff6, Reference Bosetti, Spertini and Parpinel17Reference Fink, Steck and Wolff20, Reference Lagiou, Rossi and Lagiou22Reference Rossi, Negri and Lagiou25, Reference Frankenfeld, Cerhan and Cozen53). Concerning cancers of the digestive system, when the mean consumption of anthocyanidins is low ( <  20 mg/d), non-significant associations have been reported for upper aero-digestive and colorectal cancer, colorectal and oesophageal squamous cell cancer in the Iowa Women's Health Study(Reference Cutler, Nettleton and Ross19), the Kuopio Ischaemic Heart Disease Risk Factor Study(Reference Mursu, Nurmi and Tuomainen23) and a US case–control study(Reference Bobe, Peterson and Gridley11), respectively. However, when their mean intake is high (southern European countries), a protective effect against colorectal, oral cavity, pharyngeal and laryngeal oesophageal cancers comparing extreme quintiles has been observed, although the trend analysis has usually not been significant(Reference Rossi, Garavello and Talamini12Reference Rossi, Negri and Talamini15). Gastric cancer has only been studied in a Greek case–control study, in which no statistical association with anthocyanidin intake was shown, even though the mean intake was slightly high (20·4 mg/d)(Reference Lagiou, Samoli and Lagiou21). More recently, anthocyanidins have been shown to reach some brain regions after consumption of blueberries in rats(Reference Andres-Lacueva, Shukitt-Hale and Galli54); therefore they are able to cross the haemato–encephalic barrier. This finding suggests the potential role of anthocyanidins as anti-inflammatory and antioxidant agents against the deleterious effects of ageing and its related neurodegenerative diseases(Reference Shukitt-Hale, Lau and Joseph55) and in improving memory function in older adults(Reference Krikorian, Shidler and Nash56). Further basic and epidemiological investigation is needed to confirm these potential effects against cancer and cardiovascular and neurodegenerative diseases, but taking into account possible differences among individual anthocyanidins.

To our knowledge, this is a unique study and the largest to date describing anthocyanidin intake across several European countries. However, as not all the EPIC cohorts are representative of the population, the observed level of intake cannot be extrapolated to the general population of each region. Another limitation of the present study is an underestimation of the real anthocyanidin intake, because there are some food items with missing composition data. However, our database was compiled from the most updated flavonoid databases, with only 10 % of missing values. Indeed, the major strength of the present study is the use of a unique and specifically developed FCDB, for that allowed results to be compared across countries. Further underestimation may be due to the omission of dietetic supplements in this analysis. However, there are few consumers of herb or plant supplements in the present study (up to 5 % in Denmark, the highest consumer country)(Reference Skeie, Braaten and Hjartaker57).

The present study generated data for total and individual anthocyanidin intakes among twenty-seven centres in ten European countries, according to sex, age and some lifestyle factors. Main food sources and differences among European regions were also identified. These descriptive data will be valuable for future aetiological research focused on the relationships between anthocyanidins and chronic diseases.

Acknowledgements

The present study was carried out with the financial support of the European Commission: Public Health and Consumer Protection Directorate 1993 to 2004; Research Directorate-General 2005; Ligue contre le Cancer; Institut Gustave Roussy; Mutuelle Générale de l'Education Nationale; Institut National de la Santé et de la Recherche Médicale (INSERM) (France); German Cancer Aid; German Cancer Research Centre; German Federal Ministry of Education and Research; Danish Cancer Society; Health Research Fund (FIS) of the Spanish Ministry of Health (RTICC, DR06/0020); the participating regional governments and institutions of Spain; Cancer Research UK; Medical Research Council, UK; the Stroke Association, UK; British Heart Foundation; Department of Health, UK; Food Standards Agency, UK; the Wellcome Trust, UK; Hellenic Ministry of Health; the Stavros Niarchos Foundation; the Hellenic Health Foundation; Italian Association for Research on Cancer; Compagnia San Paolo, Italy; Dutch Ministry of Public Health, Welfare and Sports; Dutch Ministry of Health; Dutch Prevention Funds; LK Research Funds; Dutch ZON (Zorg Onderzoek Nederland); World Cancer Research Fund (WCRF); Swedish Cancer Society; Swedish Scientific Council; Regional Government of Skane, Sweden; Nordforsk – Centre of Excellence Programme. Some authors are partners of ECNIS (Environmental Cancer Risk, Nutrition and Individual Susceptibility), a network of excellence of the 6FP of the European Community. R. Z. R. is thankful for a postdoctoral programme funded by the Fondo de Investigación Sanitaria (FIS; no. CD09/00133) from the Spanish Ministry of Science and Innovation. We thank Raul M. García for developing an application to link the FCDB and the 24-HDR.

R. Z.-R. and C. A. G. designed the research; R. Z.-R. and V. K. conducted the research; R. Z.-R. and L. L.-B. performed the statistical analysis; R. Z.-R. wrote the manuscript; all authors critically reviewed and approved the final manuscript.

The authors are not aware of any conflict of interest.

References

1 Clifford, MN (2000) Anthocyanins – nature, occurrence and dietary burden. J Sci Food Agric 80, 11261137.3.0.CO;2-0>CrossRefGoogle Scholar
2 Anderson, OM & Jordheim, M (2006) The anthocyanins. In Flavonoids: Chemistry, Biochemistry and Applications, pp. 472551 [Anderson, OM and Markham, KR, editors]. Boca Raton, FL: CRC Press/Taylor & Francis Group.Google Scholar
3 US Departament of Agriculture (2007) USDA Database for the Flavonoid Content of Selected Foods, Release 2.1 ed. Beltsville, MD: USDA.Google Scholar
4 Perez-Jimenez, J, Neveu, V, Vos, F, et al. (2010) Systematic analysis of the content of 502 polyphenols in 452 foods and beverages: an application of the Phenol-Explorer database. J Agric Food Chem 58, 49594969.CrossRefGoogle ScholarPubMed
5 Manach, C, Scalbert, A, Morand, C, et al. (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79, 727747.CrossRefGoogle ScholarPubMed
6 Fink, BN, Steck, SE, Wolff, MS, et al. (2007) Dietary flavonoid intake and breast cancer survival among women on Long Island. Cancer Epidemiol Biomarkers Prev 16, 22852292.CrossRefGoogle ScholarPubMed
7 Tavani, A, Spertini, L, Bosetti, C, et al. (2006) Intake of specific flavonoids and risk of acute myocardial infarction in Italy. Public Health Nutr 9, 369374.CrossRefGoogle ScholarPubMed
8 Mink, PJ, Scrafford, CG, Barraj, LM, et al. (2007) Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr 85, 895909.CrossRefGoogle ScholarPubMed
9 Prior, RL & Wu, X (2006) Anthocyanins: structural characteristics that result in unique metabolic patterns and biological activities. Free Radic Res 40, 10141028.CrossRefGoogle ScholarPubMed
10 Wang, LS & Stoner, GD (2008) Anthocyanins and their role in cancer prevention. Cancer Lett 269, 281290.CrossRefGoogle ScholarPubMed
11 Bobe, G, Peterson, JJ, Gridley, G, et al. (2009) Flavonoid consumption and esophageal cancer among black and white men in the United States. Int J Cancer 125, 11471154.CrossRefGoogle ScholarPubMed
12 Rossi, M, Garavello, W, Talamini, R, et al. (2007) Flavonoids and the risk of oral and pharyngeal cancer: a case–control study from Italy. Cancer Epidemiol Biomarkers Prev 16, 16211625.CrossRefGoogle ScholarPubMed
13 Garavello, W, Rossi, M, McLaughlin, JK, et al. (2007) Flavonoids and laryngeal cancer risk in Italy. Ann Oncol 18, 11041109.CrossRefGoogle ScholarPubMed
14 Rossi, M, Garavello, W, Talamini, R, et al. (2007) Flavonoids and risk of squamous cell esophageal cancer. Int J Cancer 120, 15601564.CrossRefGoogle ScholarPubMed
15 Rossi, M, Negri, E, Talamini, R, et al. (2006) Flavonoids and colorectal cancer in Italy. Cancer Epidemiol Biomarkers Prev 15, 15551558.CrossRefGoogle ScholarPubMed
16 Bobe, G, Sansbury, LB, Albert, PS, et al. (2008) Dietary flavonoids and colorectal adenoma recurrence in the Polyp Prevention Trial. Cancer Epidemiol Biomarkers Prev 17, 13441353.CrossRefGoogle ScholarPubMed
17 Bosetti, C, Spertini, L, Parpinel, M, et al. (2005) Flavonoids and breast cancer risk in Italy. Cancer Epidemiol Biomarkers Prev 14, 805808.CrossRefGoogle ScholarPubMed
18 Bosetti, C, Rossi, M, McLaughlin, JK, et al. (2007) Flavonoids and the risk of renal cell carcinoma. Cancer Epidemiol Biomarkers Prev 16, 98101.CrossRefGoogle ScholarPubMed
19 Cutler, GJ, Nettleton, JA, Ross, JA, et al. (2008) Dietary flavonoid intake and risk of cancer in postmenopausal women: the Iowa Women's Health Study. Int J Cancer 123, 664671.CrossRefGoogle ScholarPubMed
20 Fink, BN, Steck, SE, Wolff, MS, et al. (2007) Dietary flavonoid intake and breast cancer risk among women on Long Island. Am J Epidemiol 165, 514523.CrossRefGoogle ScholarPubMed
21 Lagiou, P, Samoli, E, Lagiou, A, et al. (2004) Flavonoids, vitamin C and adenocarcinoma of the stomach. Cancer Causes Control 15, 6772.CrossRefGoogle ScholarPubMed
22 Lagiou, P, Rossi, M, Lagiou, A, et al. (2008) Flavonoid intake and liver cancer: a case–control study in Greece. Cancer Causes Control 19, 813818.CrossRefGoogle ScholarPubMed
23 Mursu, J, Nurmi, T, Tuomainen, TP, et al. (2008) Intake of flavonoids and risk of cancer in Finnish men: The Kuopio Ischaemic Heart Disease Risk Factor Study. Int J Cancer 123, 660663.CrossRefGoogle ScholarPubMed
24 Peterson, J, Lagiou, P, Samoli, E, et al. (2003) Flavonoid intake and breast cancer risk: a case–control study in Greece. Br J Cancer 89, 12551259.CrossRefGoogle Scholar
25 Rossi, M, Negri, E, Lagiou, P, et al. (2008) Flavonoids and ovarian cancer risk: a case–control study in Italy. Int J Cancer 123, 895898.CrossRefGoogle Scholar
26 Felgines, C, Talavera, S, Gonthier, MP, et al. (2003) Strawberry anthocyanins are recovered in urine as glucuro- and sulfoconjugates in humans. J Nutr 133, 12961301.CrossRefGoogle ScholarPubMed
27 Hou, DX, Yanagita, T, Uto, T, et al. (2005) Anthocyanidins inhibit cyclooxygenase-2 expression in LPS-evoked macrophages: structure–activity relationship and molecular mechanisms involved. Biochem Pharmacol 70, 417425.CrossRefGoogle ScholarPubMed
28 Johannot, L & Somerset, SM (2006) Age-related variations in flavonoid intake and sources in the Australian population. Public Health Nutr 9, 10451054.CrossRefGoogle ScholarPubMed
29 Chun, OK, Chung, SJ & Song, WO (2007) Estimated dietary flavonoid intake and major food sources of US adults. J Nutr 137, 12441252.CrossRefGoogle Scholar
30 Zamora-Ros, R, Andres-Lacueva, C, Lamuela-Raventos, RM, et al. (2010) Estimation of dietary sources and flavonoid intake in a Spanish adult population (EPIC-Spain). J Am Diet Assoc 110, 390398.CrossRefGoogle Scholar
31 Ovaskainen, ML, Torronen, R, Koponen, JM, et al. (2008) Dietary intake and major food sources of polyphenols in Finnish adults. J Nutr 138, 562566.CrossRefGoogle ScholarPubMed
32 Riboli, E & Kaaks, R (1997) The EPIC project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 26, Suppl. 1, S6S14.CrossRefGoogle ScholarPubMed
33 Riboli, E, Hunt, KJ, Slimani, N, et al. (2002) European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 5, 11131124.CrossRefGoogle Scholar
34 Slimani, N, Kaaks, R, Ferrari, P, et al. (2002) European Prospective Investigation into Cancer and Nutrition (EPIC) calibration study: rationale, design and population characteristics. Public Health Nutr 5, 11251145.CrossRefGoogle ScholarPubMed
35 Brustad, M, Skeie, G, Braaten, T, et al. (2003) Comparison of telephone vs face-to-face interviews in the assessment of dietary intake by the 24 h recall EPIC SOFT program – the Norwegian calibration study. Eur J Clin Nutr 57, 107113.CrossRefGoogle ScholarPubMed
36 Slimani, N, Ferrari, P, Ocke, M, et al. (2000) Standardization of the 24-hour diet recall calibration method used in the European Prospective Investigation into Cancer and Nutrition (EPIC): general concepts and preliminary results. Eur J Clin Nutr 54, 900917.CrossRefGoogle ScholarPubMed
37 Slimani, N, Deharveng, G, Unwin, I, et al. (2007) The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study. Eur J Clin Nutr 61, 10371056.CrossRefGoogle ScholarPubMed
38 Haftenberger, M, Schuit, AJ, Tormo, MJ, et al. (2002) Physical activity of subjects aged 50–64 years involved in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr 5, 11631176.CrossRefGoogle ScholarPubMed
39 Neveu, V, Perez-Jimenez, J, Vos, F, et al. (2010) Phenol-Explorer: an online comprehensive database on polyphenol contents in foods. Database (Oxford) 2010, bap024.CrossRefGoogle ScholarPubMed
40 Crozier, A, Lean, MEJ, McDonald, MS, et al. (1997) Quantitative analysis of the flavonoid content of commercial tomatoes, onions, lettuces, and celery. J Agric Food Chem 45, 590595.CrossRefGoogle Scholar
41 Hiemori, M, Koh, E & Mitchell, AE (2009) Influence of cooking on anthocyanins in black rice (Oryza sativa L. japonica var. SBR). J Agric Food Chem 57, 19081914.CrossRefGoogle ScholarPubMed
42 Mulinacci, N, Ieri, F, Giaccherini, C, et al. (2008) Effect of cooking on the anthocyanins, phenolic acids, glycoalkaloids, and resistant starch content in two pigmented cultivars of Solanum tuberosum L. J Agric Food Chem 56, 1183011837.CrossRefGoogle ScholarPubMed
43 Steed, LE, Truong, VD, Simunovic, J, et al. (2008) Continuous flow microwave-assisted processing and aseptic packaging of purple-fleshed sweetpotato purees. J Food Sci 73, 455462.CrossRefGoogle ScholarPubMed
44 Xu, B & Chang, SK (2008) Total phenolics, phenolic acids, isoflavones, and anthocyanins and antioxidant properties of yellow and black soybeans as affected by thermal processing. J Agric Food Chem 56, 71657175.CrossRefGoogle ScholarPubMed
45 Oliveira, C, Amaro, LF, Pinho, O, et al. (2010) Cooked blueberries: anthocyanin and anthocyanidin degradation and their radical-scavenging activity. J Agric Food Chem 58, 90069012.CrossRefGoogle ScholarPubMed
46 Sieri, S, Krogh, V, Saieva, C, et al. (2009) Alcohol consumption patterns, diet and body weight in 10 European countries. Eur J Clin Nutr 63, Suppl. 4, S81S100.CrossRefGoogle ScholarPubMed
47 Agudo, A, Slimani, N, Ocke, MC, et al. (2002) Vegetable and fruit consumption in the EPIC cohorts from 10 European countries. IARC Sci Publ 156, 99103.Google ScholarPubMed
48 Lagiou, P, Samoli, E, Lagiou, A, et al. (2006) Flavonoid classes and risk of peripheral arterial occlusive disease: a case–control study in Greece. Eur J Clin Nutr 60, 214219.CrossRefGoogle ScholarPubMed
49 Lagiou, P, Samoli, E, Lagiou, A, et al. (2004) Intake of specific flavonoid classes and coronary heart disease – a case–control study in Greece. Eur J Clin Nutr 58, 16431648.CrossRefGoogle ScholarPubMed
50 Dilis, V & Trichopoulou, A (2010) Antioxidant intakes and food sources in Greek adults. J Nutr 140, 12741279.CrossRefGoogle ScholarPubMed
51 Melby, MK, Murashima, M & Watanabe, S (2008) Phytochemical intake and relationship to past health history in Japanese women. Biofactors 22, 265269.CrossRefGoogle Scholar
52 Hooper, L, Kroon, PA, Rimm, EB, et al. (2008) Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr 88, 3850.CrossRefGoogle ScholarPubMed
53 Frankenfeld, CL, Cerhan, JR, Cozen, W, et al. (2008) Dietary flavonoid intake and non-Hodgkin lymphoma risk. Am J Clin Nutr 87, 14391445.CrossRefGoogle ScholarPubMed
54 Andres-Lacueva, C, Shukitt-Hale, B, Galli, RL, et al. (2005) Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory. Nutr Neurosci 8, 111120.CrossRefGoogle ScholarPubMed
55 Shukitt-Hale, B, Lau, FC & Joseph, JA (2008) Berry fruit supplementation and the aging brain. J Agric Food Chem 56, 636641.CrossRefGoogle ScholarPubMed
56 Krikorian, R, Shidler, MD, Nash, TA, et al. (2010) Blueberry supplementation improves memory in older adults. J Agric Food Chem 58, 39964000.CrossRefGoogle ScholarPubMed
57 Skeie, G, Braaten, T, Hjartaker, A, et al. (2009) Use of dietary supplements in the European Prospective Investigation into Cancer and Nutrition calibration study. Eur J Clin Nutr 63, Suppl. 4, S226S238.CrossRefGoogle ScholarPubMed
Figure 0

Table 1 Adjusted* daily intakes (mg/d) of total and single anthocyanidins by sex and centre ordered from south to north(Mean values with their standard errors)

Figure 1

Table 2 Percentage contribution* of intakes of individual anthocyanidins in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort by European region and sex

Figure 2

Table 3 Adjusted* daily intakes (mg/d) of total and single anthocyanidins by sex and selected characteristics(Mean values with their standard errors)

Figure 3

Table 4 Percentage contribution of food groups and some main foods to the intake of total and single anthocyanidins by European region*

Supplementary material: File

Zamora-Ros Supplementary Material

Zamora-Ros Supplementary Tables

Download Zamora-Ros Supplementary Material(File)
File 230.9 KB